EEG machine learning for accurate detection of cholinergic intervention and Alzheimer’s disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EEG machine learning for accurate detection of cholinergic intervention and Alzheimer’s disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-12
DOI
10.1038/s41598-017-06165-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects
- (2016) Ricardo Alvarez-Jimenez et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies
- (2016) Todd E. Golde JOURNAL OF NEUROCHEMISTRY
- Current and experimental treatments of Parkinson disease: A guide for neuroscientists
- (2016) Wolfgang Oertel et al. JOURNAL OF NEUROCHEMISTRY
- The Acetylcholine Index: An Electroencephalographic Marker of Cholinergic Activity in the Living Human Brain Applied to Alzheimer's Disease and Other Dementias
- (2014) Magnus Johannsson et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
- (2014) Elisabeth CW van Straaten et al. Alzheimers Research & Therapy
- EEG and MEG: Relevance to Neuroscience
- (2013) Fernando Lopes da Silva NEURON
- Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
- (2013) Simon-Shlomo Poil et al. Frontiers in Aging Neuroscience
- Wavelet Coherence Model for Diagnosis of Alzheimer Disease
- (2012) Ziad Sankari et al. CLINICAL EEG AND NEUROSCIENCE
- Detrended Fluctuation Analysis: A Scale-Free View on Neuronal Oscillations
- (2012) Richard Hardstone et al. Frontiers in Physiology
- Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects
- (2011) Marieke Liem-Moolenaar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Validity of the Quantitative EEG Statistical Pattern Recognition Method in Diagnosing Alzheimer’s Disease
- (2011) Nina Ommundsen et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Fast network oscillations in vitro exhibit a slow decay of temporal auto-correlations
- (2011) Simon-Shlomo Poil et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Regression shrinkage and selection via the lasso: a retrospective
- (2011) Robert Tibshirani JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
- Donepezil Impairs Memory in Healthy Older Subjects: Behavioural, EEG and Simultaneous EEG/fMRI Biomarkers
- (2011) Joshua H. Balsters et al. PLoS One
- Neuronal assembly dynamics in the beta1 frequency range permits short-term memory
- (2011) N. Kopell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans
- (2011) William Cho et al. PSYCHOPHARMACOLOGY
- Aligning strategies for using EEG as a surrogate biomarker: A review of preclinical and clinical research
- (2010) Steven C. Leiser et al. BIOCHEMICAL PHARMACOLOGY
- A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy
- (2010) Ahmad Khodayari-Rostamabad et al. CLINICAL NEUROPHYSIOLOGY
- Diagnosis of Alzheimers Disease from EEG Signals: Where Are We Standing?
- (2010) J. Dauwels et al. Current Alzheimer Research
- The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects
- (2010) M Liem-Moolenaar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Developing drug prototypes: pharmacology replaces safety and tolerability?
- (2010) Adam F. Cohen NATURE REVIEWS DRUG DISCOVERY
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies
- (2010) Inge Klinkenberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects
- (2009) M Liem-Moolenaar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A comparative study of synchrony measures for the early diagnosis of Alzheimer's disease based on EEG
- (2009) J. Dauwels et al. NEUROIMAGE
- Altered temporal correlations in parietal alpha and prefrontal theta oscillations in early-stage Alzheimer disease
- (2009) T. Montez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Determination of Sleep Stage Separation Ability of Features Extracted from EEG Signals Using Principle Component Analysis
- (2008) Cabir Vural et al. JOURNAL OF MEDICAL SYSTEMS
- Effect of intrapulmonary tetrahydrocannabinol administration in humans
- (2008) L. Zuurman et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults
- (2008) Elizabeth Thomas et al. NEUROPSYCHOLOGIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search